A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)
Clinical trial NCT05904886 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05904886
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2025-05-08
- Enrollment
- 687
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.